SAMHD1 is a fundamental
regulator of cellular dNTPs that catalyzes
their hydrolysis into 2′-deoxynucleoside and triphosphate,
restricting the replication of viruses, including HIV-1, in CD4+ myeloid lineage and resting T-cells. SAMHD1 mutations are
associated with the autoimmune disease Aicardi-Goutières syndrome
(AGS) and certain cancers. More recently, SAMHD1 has been linked to
anticancer drug resistance and the suppression of the interferon response
to cytosolic nucleic acids after DNA damage. Here, we probe dNTP hydrolysis
and inhibition of SAMHD1 using the Rp and Sp diastereomers of dNTPαS nucleotides. Our biochemical and enzymological
data show that the α-phosphorothioate substitution in Sp-dNTPαS but not Rp-dNTPαS diastereomers
prevents Mg2+ ion coordination at both the allosteric and
catalytic sites, rendering SAMHD1 unable to form stable, catalytically
active homotetramers or hydrolyze substrate dNTPs at the catalytic
site. Furthermore, we find that Sp-dNTPαS diastereomers
competitively inhibit dNTP hydrolysis, while Rp-dNTPαS
nucleotides stabilize tetramerization and are hydrolyzed with similar
kinetic parameters to cognate dNTPs. For the first time, we present
a cocrystal structure of SAMHD1 with a substrate, Rp-dGTPαS,
in which an Fe–Mg-bridging water species is poised for nucleophilic
attack on the Pα. We conclude that it is the incompatibility
of Mg2+, a hard Lewis acid, and the α-phosphorothioate
thiol, a soft Lewis base, that prevents the Sp-dNTPαS
nucleotides coordinating in a catalytically productive conformation.
On the basis of these data, we present a model for SAMHD1 stereospecific
hydrolysis of Rp-dNTPαS nucleotides and for a mode
of competitive inhibition by Sp-dNTPαS nucleotides
that competes with formation of the enzyme–substrate complex.